Jazz Pharmaceuticals - JAZZ Competitors

Jazz Pharmaceuticals (NASDAQ:JAZZ) and Perrigo (NYSE:PRGO) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, media sentiment, community ranking, dividends, risk and profitability.

Which has more volatility and risk, JAZZ or PRGO?

Jazz Pharmaceuticals has a beta of 0.73, suggesting that its share price is 27% less volatile than the S&P 500. Comparatively, Perrigo has a beta of 0.79, suggesting that its share price is 21% less volatile than the S&P 500.

Does the media prefer JAZZ or PRGO?

In the previous week, Jazz Pharmaceuticals had 3 more articles in the media than Perrigo. MarketBeat recorded 9 mentions for Jazz Pharmaceuticals and 6 mentions for Perrigo. Jazz Pharmaceuticals' average media sentiment score of 0.96 beat Perrigo's score of 0.39 indicating that Jazz Pharmaceuticals is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Jazz Pharmaceuticals	6 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Perrigo	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Does the MarketBeat Community prefer JAZZ or PRGO?

Jazz Pharmaceuticals received 310 more outperform votes than Perrigo when rated by MarketBeat users. Likewise, 80.40% of users gave Jazz Pharmaceuticals an outperform vote while only 66.97% of users gave Perrigo an outperform vote.

Company	Underperform	Outperform
Jazz Pharmaceuticals	Outperform Votes 1058 80.40%	Underperform Votes 258 19.60%
Perrigo	Outperform Votes 748 66.97%	Underperform Votes 369 33.03%

Do institutionals & insiders believe in JAZZ or PRGO?

89.8% of Jazz Pharmaceuticals shares are owned by institutional investors. Comparatively, 94.1% of Perrigo shares are owned by institutional investors. 4.4% of Jazz Pharmaceuticals shares are owned by insiders. Comparatively, 0.8% of Perrigo shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Is JAZZ or PRGO more profitable?

Perrigo has a net margin of -2.91% compared to Jazz Pharmaceuticals' net margin of -6.12%. Jazz Pharmaceuticals' return on equity of 24.04% beat Perrigo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jazz Pharmaceuticals	-6.12%	24.04%	6.88%
Perrigo	-2.91%	5.79%	2.61%

Which has stronger earnings & valuation, JAZZ or PRGO?

Perrigo has higher revenue and earnings than Jazz Pharmaceuticals. Jazz Pharmaceuticals is trading at a lower price-to-earnings ratio than Perrigo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jazz Pharmaceuticals	$3.66 billion	2.38	-$224.06 million	-$3.55	-38.68
Perrigo	$4.45 billion	1.00	-$140.60 million	-$0.96	-34.38

Do analysts rate JAZZ or PRGO?

Jazz Pharmaceuticals presently has a consensus target price of $204.27, suggesting a potential upside of 48.76%. Perrigo has a consensus target price of $48.00, suggesting a potential upside of 45.45%. Given Jazz Pharmaceuticals' higher probable upside, equities research analysts clearly believe Jazz Pharmaceuticals is more favorable than Perrigo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jazz Pharmaceuticals	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88
Perrigo	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Jazz Pharmaceuticals beats Perrigo on 10 of the 18 factors compared between the two stocks.